PAX8 (+)/p63 (-) Immunostaining Pattern in Renal Collecting Duct Carcinoma (CDC): A Useful Immunoprofile in the Differential Diagnosis of CDC Versus Urothelial Carcinoma of Upper Urinary Tract

Collecting duct carcinoma (CDC) is a relatively rare but aggressive type of renal malignancy with variable morphologic features. One of the World Health Organization diagnostic criteria for CDC is the exclusion of urothelial carcinoma of renal pelvis from the differential diagnosis. PAX8 is a novel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of surgical pathology 2010-07, Vol.34 (7), p.965-969
Hauptverfasser: ALBADINE, Roula, SCHULTZ, Luciana, ILLEI, Peter, ERTOY, Dilek, HICKS, Jessica, SHARMA, Rajni, EPSTEIN, Jonathan I, NETTO, George J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 969
container_issue 7
container_start_page 965
container_title The American journal of surgical pathology
container_volume 34
creator ALBADINE, Roula
SCHULTZ, Luciana
ILLEI, Peter
ERTOY, Dilek
HICKS, Jessica
SHARMA, Rajni
EPSTEIN, Jonathan I
NETTO, George J
description Collecting duct carcinoma (CDC) is a relatively rare but aggressive type of renal malignancy with variable morphologic features. One of the World Health Organization diagnostic criteria for CDC is the exclusion of urothelial carcinoma of renal pelvis from the differential diagnosis. PAX8 is a novel lineage restricted transcription factor expressed in renal tubules. We investigated the expression pattern of PAX8 in CDC and its utility, in combination with p63, in resolving the differential diagnosis of CDC versus upper tract urothelial carcinoma (UUC). Archival tissues from 21 CDC and 34 UUC were retrieved from our institutional files. Immunohistochemistry for PAX8 and p63 were performed on routine and tissue microarray sections using standard immunohistochemistry protocol. Intensity of nuclear staining was evaluated for each marker and assigned an incremental 0, 1+, 2+, and 3+ score. Extent of staining was categorized as focal (75%). CDC: All 21 (100%) CDC were positive for PAX8. Intensity of expression was moderate to strong (2+/3+) in 19 cases (90%). Extent of staining was diffuse in 13 of 21 tumors. The p63 was positive in 3 of 21 (14%) CDC cases (PAX8+/p63+). UUC: The 34 UUC included 5 pT1, 4 pT2, and 25 pT3/pT4 tumors. Thirty-one of 34 (91.2%) UUC were negative for PAX8, whereas 33 of 34 (97%) were p63 positive. Staining intensity was moderate in 15 cases (44%), of which 12 were nonfocal or diffuse. The unique p63-negative UUC was a pT1 tumor that was also negative for PAX8 (PAX8-/p63-). We propose the use of the combination of PAX8 and p63 in the diagnosis of poorly differentiated renal sinus epithelial neoplasms where the differential diagnosis includes CDC versus UUC. The immunoprofile of PAX8+/p63- supports the diagnosis of CDC with a sensitivity of 85.7% and a specificity of 100%. In contrast, a (PAX8-/p63+) profile supports the diagnosis of UUC with a sensitivity of 88.2% and a specificity of 100%. The inverse PAX8/p63 expression seen in CDC and UUC supports a renal tubular rather than an urothelial differentiation in CDC given the nephric lineage restriction of PAX8.
doi_str_mv 10.1097/PAS.0b013e3181dc5e8a
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3505675</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733475020</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-928f14e9f3b0d9b5c018f2c45344b63a9e686dac2900796546d013f01b5d7c3a3</originalsourceid><addsrcrecordid>eNpdkd1uFCEYhonR2LV6B8ZwYtyNmRYGmBl6YLKZ9adJEzfaNZ5NGAa2GAZGYEy8Oy9NNl1b9YiD9_meD3gBeI7RGUa8Pt-uP5-hHmGiCG7wIJlqxAOwwIyURc75Q7BAmNYFww07AU9i_IYQLhtcPgYnJaIVYTVegF_b9dcGLl-vzqeKwGWxgpfjODsfkzDOuD3cipRUcNA4-Ek5YWHrrVUyHbLNLBNsRZDG-VHAZbtpVxdwDXdR6dkeTVPw2lh1EKQbBTdGaxWUSya7Nkbs8y4TodcwT8MvKsQ5wl3wmbUH5F6fkd00qZBT40T4Ca-DkOkpeKSFjerZ8TwFu3dvr9sPxdXH95ft-qqQhKJU8LLRmCquSY8G3jOJcKNLSRmhtK-I4KpqqkHIkiNU84rRashfqxHu2VBLIsgpeHPrneZ-VIPMLwjCdlMwY75L54Xp_k2cuen2_kdHGGJVzbLg1VEQ_PdZxdSNJkplrXDKz7GrCaE1QyXKJL0lZfAxBqXvtmDUHbrvcvfd_93nsRd_3_Bu6E_ZGXh5BESUwuognDTxnis5RZRw8huktLmo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733475020</pqid></control><display><type>article</type><title>PAX8 (+)/p63 (-) Immunostaining Pattern in Renal Collecting Duct Carcinoma (CDC): A Useful Immunoprofile in the Differential Diagnosis of CDC Versus Urothelial Carcinoma of Upper Urinary Tract</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>ALBADINE, Roula ; SCHULTZ, Luciana ; ILLEI, Peter ; ERTOY, Dilek ; HICKS, Jessica ; SHARMA, Rajni ; EPSTEIN, Jonathan I ; NETTO, George J</creator><creatorcontrib>ALBADINE, Roula ; SCHULTZ, Luciana ; ILLEI, Peter ; ERTOY, Dilek ; HICKS, Jessica ; SHARMA, Rajni ; EPSTEIN, Jonathan I ; NETTO, George J</creatorcontrib><description>Collecting duct carcinoma (CDC) is a relatively rare but aggressive type of renal malignancy with variable morphologic features. One of the World Health Organization diagnostic criteria for CDC is the exclusion of urothelial carcinoma of renal pelvis from the differential diagnosis. PAX8 is a novel lineage restricted transcription factor expressed in renal tubules. We investigated the expression pattern of PAX8 in CDC and its utility, in combination with p63, in resolving the differential diagnosis of CDC versus upper tract urothelial carcinoma (UUC). Archival tissues from 21 CDC and 34 UUC were retrieved from our institutional files. Immunohistochemistry for PAX8 and p63 were performed on routine and tissue microarray sections using standard immunohistochemistry protocol. Intensity of nuclear staining was evaluated for each marker and assigned an incremental 0, 1+, 2+, and 3+ score. Extent of staining was categorized as focal (&lt;25%), nonfocal (25% to 75%), or diffuse (&gt;75%). CDC: All 21 (100%) CDC were positive for PAX8. Intensity of expression was moderate to strong (2+/3+) in 19 cases (90%). Extent of staining was diffuse in 13 of 21 tumors. The p63 was positive in 3 of 21 (14%) CDC cases (PAX8+/p63+). UUC: The 34 UUC included 5 pT1, 4 pT2, and 25 pT3/pT4 tumors. Thirty-one of 34 (91.2%) UUC were negative for PAX8, whereas 33 of 34 (97%) were p63 positive. Staining intensity was moderate in 15 cases (44%), of which 12 were nonfocal or diffuse. The unique p63-negative UUC was a pT1 tumor that was also negative for PAX8 (PAX8-/p63-). We propose the use of the combination of PAX8 and p63 in the diagnosis of poorly differentiated renal sinus epithelial neoplasms where the differential diagnosis includes CDC versus UUC. The immunoprofile of PAX8+/p63- supports the diagnosis of CDC with a sensitivity of 85.7% and a specificity of 100%. In contrast, a (PAX8-/p63+) profile supports the diagnosis of UUC with a sensitivity of 88.2% and a specificity of 100%. The inverse PAX8/p63 expression seen in CDC and UUC supports a renal tubular rather than an urothelial differentiation in CDC given the nephric lineage restriction of PAX8.</description><identifier>ISSN: 0147-5185</identifier><identifier>EISSN: 1532-0979</identifier><identifier>DOI: 10.1097/PAS.0b013e3181dc5e8a</identifier><identifier>PMID: 20463571</identifier><identifier>CODEN: AJSPDX</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Biomarkers, Tumor - metabolism ; Carcinoma, Renal Cell - diagnosis ; Carcinoma, Transitional Cell - diagnosis ; Diagnosis, Differential ; Female ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Kidney Neoplasms - diagnosis ; Kidneys ; Male ; Medical sciences ; Middle Aged ; Nephrology. Urinary tract diseases ; Paired Box Transcription Factors - metabolism ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; PAX8 Transcription Factor ; Trans-Activators - metabolism ; Transcription Factors ; Tumor Suppressor Proteins - metabolism ; Tumors of the urinary system ; Urothelium - pathology</subject><ispartof>The American journal of surgical pathology, 2010-07, Vol.34 (7), p.965-969</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 by Lippincott Williams &amp; Wilkins 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c340t-928f14e9f3b0d9b5c018f2c45344b63a9e686dac2900796546d013f01b5d7c3a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22940439$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20463571$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ALBADINE, Roula</creatorcontrib><creatorcontrib>SCHULTZ, Luciana</creatorcontrib><creatorcontrib>ILLEI, Peter</creatorcontrib><creatorcontrib>ERTOY, Dilek</creatorcontrib><creatorcontrib>HICKS, Jessica</creatorcontrib><creatorcontrib>SHARMA, Rajni</creatorcontrib><creatorcontrib>EPSTEIN, Jonathan I</creatorcontrib><creatorcontrib>NETTO, George J</creatorcontrib><title>PAX8 (+)/p63 (-) Immunostaining Pattern in Renal Collecting Duct Carcinoma (CDC): A Useful Immunoprofile in the Differential Diagnosis of CDC Versus Urothelial Carcinoma of Upper Urinary Tract</title><title>The American journal of surgical pathology</title><addtitle>Am J Surg Pathol</addtitle><description>Collecting duct carcinoma (CDC) is a relatively rare but aggressive type of renal malignancy with variable morphologic features. One of the World Health Organization diagnostic criteria for CDC is the exclusion of urothelial carcinoma of renal pelvis from the differential diagnosis. PAX8 is a novel lineage restricted transcription factor expressed in renal tubules. We investigated the expression pattern of PAX8 in CDC and its utility, in combination with p63, in resolving the differential diagnosis of CDC versus upper tract urothelial carcinoma (UUC). Archival tissues from 21 CDC and 34 UUC were retrieved from our institutional files. Immunohistochemistry for PAX8 and p63 were performed on routine and tissue microarray sections using standard immunohistochemistry protocol. Intensity of nuclear staining was evaluated for each marker and assigned an incremental 0, 1+, 2+, and 3+ score. Extent of staining was categorized as focal (&lt;25%), nonfocal (25% to 75%), or diffuse (&gt;75%). CDC: All 21 (100%) CDC were positive for PAX8. Intensity of expression was moderate to strong (2+/3+) in 19 cases (90%). Extent of staining was diffuse in 13 of 21 tumors. The p63 was positive in 3 of 21 (14%) CDC cases (PAX8+/p63+). UUC: The 34 UUC included 5 pT1, 4 pT2, and 25 pT3/pT4 tumors. Thirty-one of 34 (91.2%) UUC were negative for PAX8, whereas 33 of 34 (97%) were p63 positive. Staining intensity was moderate in 15 cases (44%), of which 12 were nonfocal or diffuse. The unique p63-negative UUC was a pT1 tumor that was also negative for PAX8 (PAX8-/p63-). We propose the use of the combination of PAX8 and p63 in the diagnosis of poorly differentiated renal sinus epithelial neoplasms where the differential diagnosis includes CDC versus UUC. The immunoprofile of PAX8+/p63- supports the diagnosis of CDC with a sensitivity of 85.7% and a specificity of 100%. In contrast, a (PAX8-/p63+) profile supports the diagnosis of UUC with a sensitivity of 88.2% and a specificity of 100%. The inverse PAX8/p63 expression seen in CDC and UUC supports a renal tubular rather than an urothelial differentiation in CDC given the nephric lineage restriction of PAX8.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Carcinoma, Renal Cell - diagnosis</subject><subject>Carcinoma, Transitional Cell - diagnosis</subject><subject>Diagnosis, Differential</subject><subject>Female</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Kidney Neoplasms - diagnosis</subject><subject>Kidneys</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Paired Box Transcription Factors - metabolism</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>PAX8 Transcription Factor</subject><subject>Trans-Activators - metabolism</subject><subject>Transcription Factors</subject><subject>Tumor Suppressor Proteins - metabolism</subject><subject>Tumors of the urinary system</subject><subject>Urothelium - pathology</subject><issn>0147-5185</issn><issn>1532-0979</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkd1uFCEYhonR2LV6B8ZwYtyNmRYGmBl6YLKZ9adJEzfaNZ5NGAa2GAZGYEy8Oy9NNl1b9YiD9_meD3gBeI7RGUa8Pt-uP5-hHmGiCG7wIJlqxAOwwIyURc75Q7BAmNYFww07AU9i_IYQLhtcPgYnJaIVYTVegF_b9dcGLl-vzqeKwGWxgpfjODsfkzDOuD3cipRUcNA4-Ek5YWHrrVUyHbLNLBNsRZDG-VHAZbtpVxdwDXdR6dkeTVPw2lh1EKQbBTdGaxWUSya7Nkbs8y4TodcwT8MvKsQ5wl3wmbUH5F6fkd00qZBT40T4Ca-DkOkpeKSFjerZ8TwFu3dvr9sPxdXH95ft-qqQhKJU8LLRmCquSY8G3jOJcKNLSRmhtK-I4KpqqkHIkiNU84rRashfqxHu2VBLIsgpeHPrneZ-VIPMLwjCdlMwY75L54Xp_k2cuen2_kdHGGJVzbLg1VEQ_PdZxdSNJkplrXDKz7GrCaE1QyXKJL0lZfAxBqXvtmDUHbrvcvfd_93nsRd_3_Bu6E_ZGXh5BESUwuognDTxnis5RZRw8huktLmo</recordid><startdate>20100701</startdate><enddate>20100701</enddate><creator>ALBADINE, Roula</creator><creator>SCHULTZ, Luciana</creator><creator>ILLEI, Peter</creator><creator>ERTOY, Dilek</creator><creator>HICKS, Jessica</creator><creator>SHARMA, Rajni</creator><creator>EPSTEIN, Jonathan I</creator><creator>NETTO, George J</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20100701</creationdate><title>PAX8 (+)/p63 (-) Immunostaining Pattern in Renal Collecting Duct Carcinoma (CDC): A Useful Immunoprofile in the Differential Diagnosis of CDC Versus Urothelial Carcinoma of Upper Urinary Tract</title><author>ALBADINE, Roula ; SCHULTZ, Luciana ; ILLEI, Peter ; ERTOY, Dilek ; HICKS, Jessica ; SHARMA, Rajni ; EPSTEIN, Jonathan I ; NETTO, George J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-928f14e9f3b0d9b5c018f2c45344b63a9e686dac2900796546d013f01b5d7c3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Carcinoma, Renal Cell - diagnosis</topic><topic>Carcinoma, Transitional Cell - diagnosis</topic><topic>Diagnosis, Differential</topic><topic>Female</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Kidney Neoplasms - diagnosis</topic><topic>Kidneys</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Paired Box Transcription Factors - metabolism</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>PAX8 Transcription Factor</topic><topic>Trans-Activators - metabolism</topic><topic>Transcription Factors</topic><topic>Tumor Suppressor Proteins - metabolism</topic><topic>Tumors of the urinary system</topic><topic>Urothelium - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ALBADINE, Roula</creatorcontrib><creatorcontrib>SCHULTZ, Luciana</creatorcontrib><creatorcontrib>ILLEI, Peter</creatorcontrib><creatorcontrib>ERTOY, Dilek</creatorcontrib><creatorcontrib>HICKS, Jessica</creatorcontrib><creatorcontrib>SHARMA, Rajni</creatorcontrib><creatorcontrib>EPSTEIN, Jonathan I</creatorcontrib><creatorcontrib>NETTO, George J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of surgical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ALBADINE, Roula</au><au>SCHULTZ, Luciana</au><au>ILLEI, Peter</au><au>ERTOY, Dilek</au><au>HICKS, Jessica</au><au>SHARMA, Rajni</au><au>EPSTEIN, Jonathan I</au><au>NETTO, George J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PAX8 (+)/p63 (-) Immunostaining Pattern in Renal Collecting Duct Carcinoma (CDC): A Useful Immunoprofile in the Differential Diagnosis of CDC Versus Urothelial Carcinoma of Upper Urinary Tract</atitle><jtitle>The American journal of surgical pathology</jtitle><addtitle>Am J Surg Pathol</addtitle><date>2010-07-01</date><risdate>2010</risdate><volume>34</volume><issue>7</issue><spage>965</spage><epage>969</epage><pages>965-969</pages><issn>0147-5185</issn><eissn>1532-0979</eissn><coden>AJSPDX</coden><abstract>Collecting duct carcinoma (CDC) is a relatively rare but aggressive type of renal malignancy with variable morphologic features. One of the World Health Organization diagnostic criteria for CDC is the exclusion of urothelial carcinoma of renal pelvis from the differential diagnosis. PAX8 is a novel lineage restricted transcription factor expressed in renal tubules. We investigated the expression pattern of PAX8 in CDC and its utility, in combination with p63, in resolving the differential diagnosis of CDC versus upper tract urothelial carcinoma (UUC). Archival tissues from 21 CDC and 34 UUC were retrieved from our institutional files. Immunohistochemistry for PAX8 and p63 were performed on routine and tissue microarray sections using standard immunohistochemistry protocol. Intensity of nuclear staining was evaluated for each marker and assigned an incremental 0, 1+, 2+, and 3+ score. Extent of staining was categorized as focal (&lt;25%), nonfocal (25% to 75%), or diffuse (&gt;75%). CDC: All 21 (100%) CDC were positive for PAX8. Intensity of expression was moderate to strong (2+/3+) in 19 cases (90%). Extent of staining was diffuse in 13 of 21 tumors. The p63 was positive in 3 of 21 (14%) CDC cases (PAX8+/p63+). UUC: The 34 UUC included 5 pT1, 4 pT2, and 25 pT3/pT4 tumors. Thirty-one of 34 (91.2%) UUC were negative for PAX8, whereas 33 of 34 (97%) were p63 positive. Staining intensity was moderate in 15 cases (44%), of which 12 were nonfocal or diffuse. The unique p63-negative UUC was a pT1 tumor that was also negative for PAX8 (PAX8-/p63-). We propose the use of the combination of PAX8 and p63 in the diagnosis of poorly differentiated renal sinus epithelial neoplasms where the differential diagnosis includes CDC versus UUC. The immunoprofile of PAX8+/p63- supports the diagnosis of CDC with a sensitivity of 85.7% and a specificity of 100%. In contrast, a (PAX8-/p63+) profile supports the diagnosis of UUC with a sensitivity of 88.2% and a specificity of 100%. The inverse PAX8/p63 expression seen in CDC and UUC supports a renal tubular rather than an urothelial differentiation in CDC given the nephric lineage restriction of PAX8.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>20463571</pmid><doi>10.1097/PAS.0b013e3181dc5e8a</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0147-5185
ispartof The American journal of surgical pathology, 2010-07, Vol.34 (7), p.965-969
issn 0147-5185
1532-0979
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3505675
source MEDLINE; Journals@Ovid Complete
subjects Adult
Aged
Aged, 80 and over
Biological and medical sciences
Biomarkers, Tumor - metabolism
Carcinoma, Renal Cell - diagnosis
Carcinoma, Transitional Cell - diagnosis
Diagnosis, Differential
Female
Humans
Investigative techniques, diagnostic techniques (general aspects)
Kidney Neoplasms - diagnosis
Kidneys
Male
Medical sciences
Middle Aged
Nephrology. Urinary tract diseases
Paired Box Transcription Factors - metabolism
Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques
PAX8 Transcription Factor
Trans-Activators - metabolism
Transcription Factors
Tumor Suppressor Proteins - metabolism
Tumors of the urinary system
Urothelium - pathology
title PAX8 (+)/p63 (-) Immunostaining Pattern in Renal Collecting Duct Carcinoma (CDC): A Useful Immunoprofile in the Differential Diagnosis of CDC Versus Urothelial Carcinoma of Upper Urinary Tract
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T06%3A09%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PAX8%20(+)/p63%20(-)%20Immunostaining%20Pattern%20in%20Renal%20Collecting%20Duct%20Carcinoma%20(CDC):%20A%20Useful%20Immunoprofile%20in%20the%20Differential%20Diagnosis%20of%20CDC%20Versus%20Urothelial%20Carcinoma%20of%20Upper%20Urinary%20Tract&rft.jtitle=The%20American%20journal%20of%20surgical%20pathology&rft.au=ALBADINE,%20Roula&rft.date=2010-07-01&rft.volume=34&rft.issue=7&rft.spage=965&rft.epage=969&rft.pages=965-969&rft.issn=0147-5185&rft.eissn=1532-0979&rft.coden=AJSPDX&rft_id=info:doi/10.1097/PAS.0b013e3181dc5e8a&rft_dat=%3Cproquest_pubme%3E733475020%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733475020&rft_id=info:pmid/20463571&rfr_iscdi=true